Belgium· BE-AMP-SAM065186-00
Ferograd 525 mg - 500 mg
A eisen und multivitamine product containing ferrous sulfate heptahydrate, registered in Belgium by Teofarma. The same ATC class is registered in 2 of our 19 countries.
Checked against FAMHP / AFMPS (Belgium) on
Informational only — not a medical device.
Where it is registered
Eisen und multivitamine is registered in 2 of 19 countries.
Countries holding a registration under ATC B03AE03 (eisen und multivitamine), each read from that country’s own register.
- This record: Belgium, from FAMHP / AFMPS (Belgium)
- 2 of them publish a price we can compare per daily dose
Eisen und multivitamine · ATC B03AE03
2 / 19 countries
- Belgiumprice
- Finlandprice
The record
At a glance
FAMHP / AFMPS (Belgium)- Active substance
- Ferrous Sulfate Heptahydrate
- Manufacturer
- Teofarma
- Country
- Belgium (BE)
- ATC code
- B03AE03
- ATC class
- Eisen und Multivitamine
- Reimbursed
- Not published by this register
- Source register
- FAMHP / AFMPS (Belgium)
- Last checked
- September 26, 2026
Packs & prices · 2
- be_apb0110759
- be_apb0112540
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
1 interaction on record for eisen und multivitamine.
Mechanism, severity and management for each pair, from a commercially licensed source — included with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Eisen und multivitamine · interactions on record
1 record
1 more interaction with mechanism and management, from a commercially licensed source.
Sign in to checkSame medicine, other countries
Eisen und multivitamine in 12 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomActiFerr-S 200mg tabletsMaN Pharma Ltd
- PolandObsidanInPharm Sp. z o.o.
- United StatesFerrous SulfateRichmond Pharmaceuticals Inc.
- FranceFER AP-HP 0,5 mg NOUVEAU-NE, géluleASSISTANCE PUBLIQUE - HOPITAUX DE PARIS - AP-HP
- NorwayDuroferonPerrigo Sverige AB
- FinlandMicroferPfizer Health Ab
- GermanyEisensulfat LomapharmLomapharm Gmbh
- ItalyFERRO-GRAD*40 cpr 105 mg rilascio prolungatoTEOFARMA Srl
Authorised across Europe · EMA
The same active substance is authorised in 12 EEA countries. Names it is sold under:
- Austria · Ferro - Gradumet
- Germany · Eisensulfat Lomapharm, Ferro Aiwa
- Spain · Ferogradumet
- France · Fer Nouveau-Ne Ap-Hp
- United Kingdom (Northern Ireland) · Feospan, Ferrous Sulfate Wockhardt Uk
- Greece · Tardyferon
- Hungary · Ferro-Gradumet
- Lithuania · Tardyferon
- Luxembourg · Fero-Gradumet
- Norway · Duroferon, Ferromax
- Portugal · Ferro-Gradumet
- Slovakia · Tardyferon
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/f478ad58-a606-429e-a7e7-c7e951cc3bc4 GET /v1/drugs/f478ad58-a606-429e-a7e7-c7e951cc3bc4?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Coated tablet",
"source": "afmps",
"status": "AUTHORIZED",
"name_en": "Ferograd 525 mg - 500 mg",
"name_fr": "Ferograd 525 mg - 500 mg",
"name_nl": "Ferograd 525 mg - 500 mg",
"amp_code": "SAM065186-00",
"strengths": [
"525.0000",
"105.0000",
"500.0000"
],
"pack_count": 2,
"substances": [
"Ferrous Sulfate Heptahydrate",
"Iron",
"Sodium Ascorbate"
],
"medicine_type": "ALLOPATHIC",
"atc_description": "Iron and Multivitamins",
"authorisation_numbers": [
"BE065186"
]
}See everything about eisen und multivitamine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.